Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/CE

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 4.769.57-0.030.06-0.07

What is the latest EV/CE ratio of MANKIND PHARMA ?

The latest EV/CE ratio of MANKIND PHARMA is 4.76 based on Mar2025 Consolidated results.
Year EV/CE
Mar20254.76
Mar20249.57
Mar2023-0.03
Mar20220.06
Mar2021-0.07

How is EV/CE of MANKIND PHARMA Trending?

Years EV/CE % Change
Mar2025 4.76
-50.26
Mar2024 9.57
Positive
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/CE ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,177.3 Cr -4.1% 4.8% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.1%

4.8%

-0.6%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses